| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |